Exosome Diagnostics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Exosome Diagnostics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7015
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA profiling, mutation detection, ribonucleic acid (RNA) sequencing (including full RNA seq) and custom assay development services. The company also offers disease detection, diagnosis, treatment and monitoring. Its technology is used in the treatment of brain cancer, prostate cancer, and Alzheimer’s disease. Exosome Diagnostics is headquartered in Waltham, Massachusetts the US.

Exosome Diagnostics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Exosome Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Exosome Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Exosome Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Exosome Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Exosome Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Exosome Diagnostics Inc, Medical Equipment, Deal Details 12
Venture Financing 12
Exosome Diagnostics Raises USD60 Million in Series B Financing Round 12
Exosome Diagnostics Raises Additional USD17.6 Million in Series B Financing 14
Exosome Diagnostics Raises USD1.5 Million in Financing Round 15
Exosome Diagnostics to Raise USD25 Million in Venture Financing 16
Exosome Diagnostics Raises US$27 Million In Series B Financing Round 17
Exosome Diagnostics Raises US$7 Million In Venture Financing 19
Exosome Diagnostics Raises USD3 Million in Venture Financing 20
Partnerships 21
Exosome Diagnostics Enters into Agreement with Intezyne 21
Exosome Diagnostics Enters into Agreement with Merck 22
Exosome Diagnostics Enters into Agreement with Amgen 23
Exosome Diagnostics Enters into Agreement with Takeda Pharma 24
Exosome Diagnostics Enters into Agreement with Addario Lung Cancer Medical Institute 25
Qiagen And Exosome Diagnostics Enter Into Agreement To Develop Diagnostics For Cancer Biomarkers 26
Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 27
Exosome Diagnostics Enters Into Research Agreement With Mount Sinai Hospital 28
Exosome Diagnostics And Qiagen Enter Into Agreement To Develop Line Of Biofluid Nucleic Acid Kits 29
Exosome Diagnostics Enters Into Co-Development Agreement With Promega For Urine Clinical Sample Concentrator Kit 30
Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies 31
Acquisition 32
Bio-Techne Acquires Exosome Diagnostics 32
Exosome Diagnostics Inc – Key Competitors 33
Exosome Diagnostics Inc – Key Employees 34
Exosome Diagnostics Inc – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 36
Strategy And Business Planning 36
Aug 01, 2017: Exosome Diagnostics Announces New World Headquarters and Laboratory in Waltham, MA 36
Corporate Communications 37
Mar 21, 2018: Exosome Diagnostics Names Grannum Sant As Head Of Medical Affairs 37
Legal and Regulatory 38
Jun 13, 2018: Exosome Diagnostics Receives ISO 13485:2016 Certification 38
Aug 03, 2017: Exosome Diagnostics Achieves ISO 13485 Certification 39
Jan 18, 2017: Exosome Diagnostics Obtains ISO 15189 for Its Munich Laboratory 40
Product News 41
May 22, 2018: Exosome Diagnostics Announces Bladder Cancer Surveillance Panel 41
May 15, 2018: Exosome Diagnostics Presents Breakthrough Data Highlighting Tumor Derived RNA in Biofluids at the International Society for Extracellular Vesicles in Spain 42
Apr 17, 2018: Exosome Diagnostics Obviates Tissue Biopsies 43
Oct 11, 2017: Exosome Diagnostics to Present a Novel Atlas of Exosomal mRNA and Long non-coding RNA Across Biofluids at American Society of Exosomes and Microvesicles Annual Meeting 44
Jun 22, 2017: Exosome Diagnostics Presents Breakthrough Liquid Biopsy Technologies at BIO International Convention 45
Other Significant Developments 46
Aug 24, 2017: CareFirst BlueCross BlueShield and Exosome Diagnostics Announce Evidence Development Collaboration for Molecular Diagnostic Tests 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
Exosome Diagnostics Inc, Medical Equipment, Key Facts 2
Exosome Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Exosome Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Exosome Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Exosome Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Exosome Diagnostics Inc, Deals By Market, 2012 to YTD 2018 9
Exosome Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Exosome Diagnostics Raises USD60 Million in Series B Financing Round 12
Exosome Diagnostics Raises Additional USD17.6 Million in Series B Financing 14
Exosome Diagnostics Raises USD1.5 Million in Financing Round 15
Exosome Diagnostics to Raise USD25 Million in Venture Financing 16
Exosome Diagnostics Raises US$27 Million In Series B Financing Round 17
Exosome Diagnostics Raises US$7 Million In Venture Financing 19
Exosome Diagnostics Raises USD3 Million in Venture Financing 20
Exosome Diagnostics Enters into Agreement with Intezyne 21
Exosome Diagnostics Enters into Agreement with Merck 22
Exosome Diagnostics Enters into Agreement with Amgen 23
Exosome Diagnostics Enters into Agreement with Takeda Pharma 24
Exosome Diagnostics Enters into Agreement with Addario Lung Cancer Medical Institute 25
Qiagen And Exosome Diagnostics Enter Into Agreement To Develop Diagnostics For Cancer Biomarkers 26
Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 27
Exosome Diagnostics Enters Into Research Agreement With Mount Sinai Hospital 28
Exosome Diagnostics And Qiagen Enter Into Agreement To Develop Line Of Biofluid Nucleic Acid Kits 29
Exosome Diagnostics Enters Into Co-Development Agreement With Promega For Urine Clinical Sample Concentrator Kit 30
Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies 31
Bio-Techne Acquires Exosome Diagnostics 32
Exosome Diagnostics Inc, Key Competitors 33
Exosome Diagnostics Inc, Key Employees 34
Exosome Diagnostics Inc, Subsidiaries 35

List of Figures
Exosome Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Exosome Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Exosome Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Exosome Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Exosome Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Exosome Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Exosome Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Exosome Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Exosome Diagnostics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Histogenics Corp (HSGX):企業の財務・戦略的SWOT分析
    Summary Histogenics Corp (Histogenics) is a regenerative medicine company that develops, markets and commercializes products for musculoskeletal disorders. The company provides product such as neocart, a tissue implant produced using a patient’s own cartilage cells which are harvested from non-weigh …
  • Syngen Biotech Co Ltd (8279):製薬・医療:M&Aディール及び事業提携情報
    Summary Syngen Biotech Co Ltd (Syngen) is a biotechnology company. The company manufactures and supplies active pharmaceutical ingredients (APIs), biology fermentation products, nutritional ingredients, nutraceutical ingredients, biology agriculture and aquaculture products, and functional food prod …
  • Fiserv, Inc.:企業の戦略・SWOT・財務情報
    Fiserv, Inc. - Strategy, SWOT and Corporate Finance Report Summary Fiserv, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Linn Energy Inc (LNGG):石油・ガス:M&Aディール及び事業提携情報
    Summary Linn Energy Inc (Linn Energy), formerly Linn Energy LLC, is an independent energy company. It explores for, develops, and produces oil, natural gas, and natural gas liquids (NGLs). The company has upstream assets in various operating regions in the US such as Hugoton Basin, the Mid-Continent …
  • Maxion Wheels Inc:企業の戦略的SWOT分析
    Maxion Wheels Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Compuware Corp:企業の戦略・SWOT・財務分析
    Compuware Corp - Strategy, SWOT and Corporate Finance Report Summary Compuware Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • The Medicines Company (MDCO)-医療機器分野:企業M&A・提携分析
    Summary The Medicines Company (TMC) is a biopharmaceutical company, which provides medical solutions for improving health conditions in patients under critical care. The company’s product portfolio comprises marketed products, namely, Angiomax (bivalirudin), Orbactiv (oritavancin), Minocin (minocycl …
  • Saipem SpA (SPM)-石油・ガス分野:企業M&A・提携分析
    Summary Saipem SpA (Saipem) is an engineering, procurement, construction (EPC) contractor. It provides integrated basic design, Pre-front end engineering design (FEED), FEED and detailed EPC and project management services for complex offshore and onshore projects in the oil and gas industry. The co …
  • Investimentos, Participacoes e Gestao SA (INA):企業の財務・戦略的SWOT分析
    Investimentos, Participacoes e Gestao SA (INA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Achaogen Inc (AKAO)-製薬・医療分野:企業M&A・提携分析
    Summary Achaogen Inc (Achaogen) is a biopharmaceutical company that discovers, develops and commercializes novel anti bacterials for the treatment of multi-drug resistant and gram-negative infections. The company is developing plazomicin for the treatment of serious bacterial infections due to MDR E …
  • Morgan Stanley Smith Barney LLC:企業の戦略的SWOT分析
    Morgan Stanley Smith Barney LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Sphere Fluidics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Sphere Fluidics Ltd (Sphere Fluidics) is a life sciences company that offers analytical instrumentation and collaborative research services. The company offers products such as research instruments, consumables and industrial systems. Its research instruments include picodroplet single cell …
  • Griffon Corporation:企業の戦略・SWOT・財務情報
    Griffon Corporation - Strategy, SWOT and Corporate Finance Report Summary Griffon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CAS Medical Systems Inc (CASM)-医療機器分野:企業M&A・提携分析
    Summary CAS Medical Systems Inc (CASMED) is a medical device company that designs, manufactures and markets technologies and monitors. The company offers products such as FORE-SIGHT absolute tissue oximeter, blood pressure measurement technology, vital signs monitors and supplies for neonatal intens …
  • Tokyo Electron Limited:企業の戦略・SWOT・財務分析
    Tokyo Electron Limited - Strategy, SWOT and Corporate Finance Report Summary Tokyo Electron Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Alexion Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析
    Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Zion Oil & Gas Inc (ZN):石油・ガス:M&Aディール及び事業提携情報
    Summary Zion Oil & Gas Inc (Zion Oil) is an oil and gas company that explores and produces oil and gas properties in Israel. The company offers services such as geophysical, geological, and other science-based studies and surveys to support oil and gas exploration and development services. It holds …
  • Macquarie Bank Ltd:企業のM&A・事業提携・投資動向
    Macquarie Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Macquarie Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • San Raffaele Hospital-製薬・医療分野:企業M&A・提携分析
    Summary San Raffaele hospital (San Raffaele), a subsidiary of Vita-Salute San Raffaele University is a clinical scientific university institution that offers education and healthcare services. The institute provides services through the segments clinic, scientific research, patient services, and hos …
  • MSIG Insurance (Singapore) Pte. Ltd.:企業の戦略・SWOT・財務情報
    MSIG Insurance (Singapore) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary MSIG Insurance (Singapore) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆